We took advantage of KI mice expressing FAD-linked PS1 variant, an AD mouse model that does not overexpress APP and PS1 mutations, to demonstrate the necessity of APP and its intracellular metabolites in the development of AD, before the emergence of overt cerebral Aβ burden. This evidence concerns the gene APP and Alzheimer disease.